¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõÀ¯»êÈÄÇÑ¾à ¼ÛµµÀ¯»êÇѾà ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼ÛµµÀ¯»êÇѾà, #¼ÛµµÀ¯»êÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»ê, #¼ÛµµÀΰøÀ¯»ê, #À¯»êÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»êÇÑÀÇ¿ø, #¼ÛµµÀΰøÀ¯»ê, #ÀÎõÀ¯»êÇÑ¾à ¼ÛµµÀ¯»êÇѾà,,¼ÛµµÀ¯»êÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»ê,,¼ÛµµÀΰøÀ¯»ê,,À¯»êÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»êÇÑÀÇ¿ø,,¼ÛµµÀΰøÀ¯»ê,,ÀÎõÀ¯»êÇÑ¾à ¾È³çÇϼ¼¿ä. ¼ÛµµÀ¯»êÇѾà ÀÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼ÛµµÀ¯»êÇѾà ÀÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÀΰøÀ¯»ê, È­ÇÐÀûÀ¯»êÈÄ»ý¸®, À¯»êÈĸö°ü¸®, È­ÇÐÀûÀ¯»êÃâÇ÷, À¯»êÈÄÇѾà, È­ÇÐÀûÀ¯»êÈÄÀÓ½Å, ¼ÒÆļúÈÄ»ý¸®, À¯»êÇѾà, È­ÇÐÀûÀ¯»ê»ý¸®, À¯»ê¼ö¼úÈÄ, ¼ÒÆļö¼úÈĸöÁ¶¸®, ¼ÒÆļö¼ú, °è·ùÀ¯»êÈĸöÁ¶¸®, ÀΰøÀ¯»êÈĸöÁ¶¸®, À¯»êÈĺ¸¾à, ÀΰøÀ¯»êÈÄ, ¼ÒÆļúÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»ê, Àΰø¼öÁ¤½ÇÆÐ, È­ÇÐÀ¯»ê, È­À¯, È­ÇÐÀûÀ¯»êÇÏÇ÷, À¯»êÈÄ°ü¸®, °è·ùÀ¯»ê, °è·ùÀ¯»êÇѾàµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó °æÇÇÀû¿Ü¼±Á¶»ç¿ä¹ý, ȣħ, TENS, ¸ÆÆÄ°Ë»ç, °üÀýº¸È£´ë, °üÀýôÃߺÀ¾àħ¿ä¹ý, ·ÑÇÎ, ¸Å¼±¿ä¹ý, ¿À°ø¾àħ, ¿îµ¿Ä¡·á, ±ØÃÊ´ÜÆÄÅõ¿­Ä¡·á, Çâ±âÀÚ°¡¿ä¹ý, ÀüÀÚ¿ä¹ý, üÁö¹æÃøÁ¤, ½ÃÇÁ°Ö, ü¿­Áø´Ü(Àü½Å), ½ÉºÎ¿­Ä¡·á, ¸Æ¹Ý¼®¿Â½ÀÂòÁú±â, heat therapy, Ư¼öÃß³ª, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² ÁøÁֽà Çϴ뵿, ÀÎõ µ¿±¸ ¸¸¼®µ¿, ÀüºÏ Á¤À¾½Ã ±ÝºØµ¿, ºÎ»ê µ¿±¸ ¹üÀÏ2µ¿, ÀÎõ µ¿±¸ ¼Û¸²6µ¿, ÀÎõ ³²±¸ ÁÖ¾È5µ¿, ÀüºÏ Á¤À¾½Ã ÅÂÀθé, ÀüºÏ ¿ÏÁÖ±º »ï·ÊÀ¾, °­¿ø ȫõ±º µÎÃ̸é, Á¦ÁÖ ¼­±ÍÆ÷½Ã µµ¼øµ¿, °æ±â Àǿսà ÃÊÆòµ¿, Ãæ³² °øÁֽà ÀÌÀθé, °æºÏ °æÁֽà ±¸È²µ¿, ÀüºÏ ÀÍ»ê½Ã ¿õÆ÷¸é, Àü³² ¿µ±¤±º ¹é¼öÀ¾, ÀüºÏ ¼øⱺ ¼øâÀ¾, °æ³² â¿ø½Ã ÁøÇر¸ ³²ºóµ¿, ÀÎõ ¿¬¼ö±¸ ¼Ûµµµ¿, °æ±â ¾çÁֽà ȸ¾Ïµ¿, ÀüºÏ ±º»ê½Ã ¼Ò·æµ¿, ÀüºÏ ÀÍ»ê½Ã ¸Á¼º¸é, °æºÏ °æ»ê½Ã ¿Á°îµ¿, ¿ï»ê ºÏ±¸ ´ç»çµ¿, °æ³² °Åⱺ ÁÖ»ó¸é, Àü³² °î¼º±º Á×°î¸é, Ãæ³² û¾ç±º ´ëÄ¡¸é, °æ±â È­¼º½Ã ¾ç°¨¸é, ÀüºÏ Á¤À¾½Ã ÇϺϵ¿, Àü³² À强±º Áø¿ø¸é, ÀüºÏ ÀüÁֽà ´öÁø±¸ È£¼ºµ¿2°¡, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼ÛµµÀ¯»êÇѾàÄ¡·á ãÀ¸½Ã´Â ÀÎõ¼­±¸, ³²¾çÀ¾, Á־ȵ¿, °Ë´Ü, µµ¸²µ¿, ±¸¿ùµ¿, ¿ëÇöµ¿, µ¿±¸, ÀÎõÁÖ¾È, ³²µ¿±¸, ³íÇö°íÀܵ¿, ¼Ûµµ½Åµµ½Ã, ÀÎõ³íÇöµ¿, ´ëºÎµµ, ³²±¸, µ¿Ãᵿ, Á־ȿª, µ¿ÀÎõ, µµÈ­µ¿, °è»êµ¿, ¸¶µµ¸é, ºÎõ, Á¤¿Õµ¿, ½ÃÈï, ¼®³²µ¿, ¿¬¼öµ¿, ¼Û¸²µ¿, û¶ó, °Ë¾Ï, ¿î¼­µ¿, Áßµ¿, °¡Áµ¿, ¼Û¿ùµ¿, À²¸ñµ¿, ûÇе¿ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Jain D. Perineal scar endometriosis: a comparison of two cases. BMJ Case Rep 2013; 2013. 2. Costello MF, Shrestha B, Eden J, et al. Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 2007; 22:1200. 3. Bata MS, Al-Ramahi M, Salhab AS, et al. Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study. J Clin Pharmacol 2006; 46:925. 4. Lundström V, Landgren BM, Eneroth P, Johannisson E. The effect of a prostaglandin synthetase inhibitor on the hormonal profile and the endometrium in women. Acta Obstet Gynecol Scand Suppl 1983; 113:77. 5. Victory R, Diamond MP, Johns DA. Villar's nodule: a case report and systematic literature review of endometriosis externa of the umbilicus. J Minim Invasive Gynecol 2007; 14:23. 6. Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod 2008; 23:100. 7. Nylander M, Fr©ªssing S, Clausen HV, et al. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online 2017; 35:121.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõÀ¯»êÈÄÇÑ¾à ¼ÛµµÀ¯»êÇѾà ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÇѹæ´ÙÀ̾îÆ® ±¸¿ùµ¿ÇÑÀÇ¿ø ±Ã±ÝÇØ¿ä
´ÙÀ½±Û ÀÎõºñ¿°ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¾î¶² µµ¿òÀ»
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
692 ÇØÀ²ÇÑÀÇ¿ø, È«´ë¿©µå¸§º´¿ø 4¿ù À̺¥Æ® ½Ç½ÃÇØ¿ä 0 2,038 2020-04-10
691 ¿¹ÀÛÇÑÀÇ¿ø, ºÎ»ê °æ³² ´ÙÀ̾îÆ® ºÎ°æ¸¾ ÇÒÀÎ À̺¥Æ®!!! Ãâ»ê ÈÄ »ìÀÌ .. 0 1,124 2020-04-01
690 ÇÏ´ÃüÇÑÀÇ¿ø Á¦ÁÖÁ¡ µîµå¸§ ÄɾîÄ¡·á À̺¥Æ® 0 1,895 2020-04-01
689 ÇÏ´ÃüÇÑÀÇ¿ø ÀÏ»êÁ¡ 4¿ù À̺¥Æ®ÀÔ´Ï´Ù 0 2,256 2020-04-01
688 ¼öÇÑÀÇ¿ø, »ê»ïºñ¸¸¾àħÀ̺¥Æ® 0 2,299 2020-04-01
687 ¸é¿ª·Â ³ôÀ̱â, ÅÂÈï´ç ÇѾà ÇÒÀÎ ÇýÅà 0 1,269 2020-03-30
686 È®ÂðÀÚ¸¦ À§ÇÑ °¨ºñȯ À̺¥Æ®°¡ ½ÃÀ۵˴ϴÙ-¸¶»ê´ÙÀ̾îÆ® ÇÑÀÇ¿ø 0 2,043 2020-03-30
685 ½Å»çÀÓ´çÇÑÀÇ¿ø ´ÙÀ̾îÆ® À̺¥Æ® 3 2,988 2020-03-30
684 ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ 2020³â 3¿ù °¡°Ý À̺¥Æ® ¾È³» 0 7,659 2020-03-25
683 ¸é¿ª·Â¿¡ ÁÁÀº °æ¿Á°í(½ºÆ½Çü)-±â°üÁö °Ç°­¿¡ È¿°ú-¸¶»êº½º½ÇÑÀÇ¿ø 0 3,006 2020-03-02
682 3¿ù ÂüÇÑÀÇ¿ø °æ¿Á°í ÇÒÀÎÀ̺¥Æ® 0 997 2020-03-02
681 2¿ù ´ÙÀ̾îÆ® ÇÒÀÎ À̺¥Æ®! ³¡³ª±â Àü¿¡ ¼­µÎ¸£¼¼¿ä¢½ ½Å¸² ´ÙÀ̾îÆ® .. 0 2,835 2020-02-27
680 ¼­¿ï°æÈñÇÑÀÇ¿ø, STARTOVER µðÅ彺ÇÁ·Î±×·¥ À̺¥Æ® 0 1,178 2020-02-24
679 ûÁÖ ¸¶À½¿¡ ²É ÇÑÀÇ¿ø ¸é¿ªÁõ°­ À̺¥Æ® 2 1,133 2020-02-24
678 ¼ö¿ø´ãÀûÇÑÀÇ¿ø À̺¥Æ® ÁøÇàÇÕ´Ï´Ù 0 4,880 2020-02-11
677 2¿ù ÂüÇÑÀÇ¿ø ÇÒÀÎ ÇÁ·Î¸ð¼Ç 0 907 2020-02-07
676 ÀºÇ೪¹«ÇÑÀÇ¿ø 2¿ùÀ̺¥Æ® °Ü¿ï¹æÇÐÀ̺¥Æ® 0 1,167 2020-02-07
675 ¼öÇÑÀÇ¿ø 2¿ù À̺¥Æ® "»õ³»±â º¸¾à À̺¥Æ®" 0 908 2020-02-07
674 2¿ù À̺¥Æ® »ç»ïûÆóÀ½ -[¸¶»êº½º½ÇÑÀÇ¿ø] 0 2,168 2020-02-04
673 ÇØÀ²ÇÑÀÇ¿ø ÀÎõÁ¡ 2¿ù À̺¥Æ® °øÁö 0 1,298 2020-02-04
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷